Contact X-ray brachytherapy for rectal cancer: Past, present, and future.
Cancer Radiother
; 25(8): 795-800, 2021 Dec.
Article
em En
| MEDLINE
| ID: mdl-34052134
ABSTRACT
The Papillon experience and the Lyon R96-02 trial have shown that contact X-ray brachytherapy of 50kV is efficient and safe to achieve long term local control and organ preservation for cT1 and early cT2-3 rectal cancers. The OPERA trial, using the Papillon 50™ machine, brings further support to this preservation strategy for selected T2T3ab lesions. Future trials using a contact X-ray boost will try to consolidate and enlarge its place in organ preservation for rectal cancers.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
/
Tipos_de_cancer
/
Colon_e_reto
/
Tratamento
/
Radioterapia
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Retais
/
Braquiterapia
/
Ensaios Clínicos Controlados Aleatórios como Assunto
/
Tratamentos com Preservação do Órgão
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Cancer Radiother
Assunto da revista:
NEOPLASIAS
/
RADIOTERAPIA
Ano de publicação:
2021
Tipo de documento:
Article